LITTLE FALLS, N.J.,
Feb. 25, 2014 /PRNewswire/ -- Cantel Medical Corp. (NYSE:
CMN) announces that the REVOX® Sterilization Solutions business is
now registered to the EN ISO 13485:2003 quality standards.
The room temperature, Peracetic Acid/Hydrogen Peroxide (PAA) vacuum
vapor process enables effective sterilization of heat and/or
chemical sensitive medical, drug delivery, diagnostic, and
implantable devices that may not be well-suited to other
sterilization processes.
Collaboratively developed and marketed by Cantel subsidiaries
Medivators and Mar Cor Purification, REVOX Sterilization Solutions
offers the first commercially available room temperature vapor
sterilization process. With full contract validation and
sterilization services as well as on-site processing potential with
multiple chamber configurations, REVOX Sterilization Solutions is
positioned to foster increased innovation and production
efficiencies for manufacturers of advanced devices.
Jorgen Hansen, COO of Cantel
Medical says, "We have seen REVOX Sterilization Solutions solve
customer issues that have impeded critical product launch
plans. With increasing sophistication of medical, diagnostic,
drug delivery, and implantable devices, it's a timely solution for
these manufacturers. This ISO registration reflects our
attention to quality within all of our business segments and
underscores our new product and market expansion capabilities
within and between our business groups."
For more information, please visit our website at
www.revoxsterilization.com.
About Cantel Medical Corp.
Cantel Medical Corp. (NYSE:
CMN) is a leading provider of infection prevention and control
products in the healthcare market. Our products include water
purification equipment, sterilants, disinfectants and cleaners,
specialized medical device reprocessing systems for endoscopy and
renal dialysis, terminal sterilization equipment and services,
disposable infection control products primarily for dental and GI
endoscopy markets, dialysate concentrates and other dialysis
supplies, hollow fiber membrane filtration and separation products
for medical and non-medical applications, and specialty packaging
for infectious and biological specimens. We also provide technical
maintenance for our products and offer compliance training services
for the transport of infectious and biological
specimens. Visit our website
at www.cantelmedical.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
SOURCE Cantel Medical Corp.